BridgeMD
Comparison of Desmopressin (Minirin vs. Sandoz) in Children with Bedwetting.
EU CTIS ID: 2025-521256-29-00
What this study is testing
Overall objective: to examine the pharmacokinetic and pharmacodynamic differences between the two desmopressin formulations (Minirin and Sandoz). 1) To examine the pharmacokinetic profiles 2) To examine the difference in the ability to concentrate the urine
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- 1. Children aged 8-14 years. 2. Diagnosis of NE. 3. 3 or more wet nights per week. 4. Completion of a 7-day home measurement of urine output and a 2-day fluid intake measurement prior to Visit 1.
You likely can't join if
- 1. Recurrent urinary tract infections. 2. Anamnestic, clinical or laboratory findings that can be related to dis-eases or conditions that might affect the parameters investigated. 3. Neurological and/or known clinically significant anatomical abnormal-ities of the urinary tract. 4. Former operations in the urinary tract. 5. Pregnant or lactating girl. 6. Contra-indications for the use of desmopressin: habitual or psychogenic polydipsia, use of diuretics, renal insufficiency, hyponatraemia or SADH.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.